Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 18 Source: CRO
- €4.2 billion turnover
-
€255.3 million
profit - 10,400 employees
-
31st Dec 17 Source: CRO
- €4.1 billion turnover
-
€229.2 million
profit - 10,400 employees
- 4 more years available »
Ranking
By Turnover
(€4.2 billion)- 29th in Top Companies
- 6th in Health
- 5th in Pharma
By Employees
(10,400)- 22nd in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.2 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- 6:30am Quinn Insurance and PwC’s audit, An Post’s gender pay gap, and theatre profits
- 5:45am Bord Gáis theatre records strong growth in turnover and profits
- 5:25am Iconic Newspapers in talks to acquire Munster Express
- 5:20am Former Elan executive Given joins Philip Lee’s corporate deals team
- 5:20am Study finds investors will give up gains for sustainable options